Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition-Reference-Cited by-同舟云学术

Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition

Published:2017-04-11 Issue:3 Volume:40 Page:247-261
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Matias Diana,Balça-Silva Joana,Dubois Luiz Gustavo,Pontes Bruno,Ferrer Valéria Pereira,Rosário Luciane,do Carmo Anália,Echevarria-Lima Juliana,Sarmento-Ribeiro Ana Bela,Lopes Maria Celeste,Moura-Neto Vivaldo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s13402-017-0320-1/fulltext.html

Reference47 articles.

1. F.B. Furnari, T. Fenton, R.M. Bachoo, A. Mukasa, J.M. Stommel, A. Stegh, W.C. Hahn, K.L. Ligon, D.N. Louis, C. Brennan, L. Chin, R.A. DePinho, W.K. Cavenee, Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes. Dev. 21, 2683–2710 (2007). doi: 10.1101/gad.1596707

2. F.R. Lima, S.A. Kahn, R.C. Soletti, D. Biasoli, T. Alves, A.C. da Fonseca, C. Garcia, L. Romao, J. Brito, R. Holanda-Afonso, J. Faria, H. Borges, V. Moura-Neto, Glioblastoma: Therapeutic challenges, what lies ahead. Biochim. Biophys. Acta. 1826, 338–349 (2012). doi: 10.1016/j.bbcan.2012.05.004

3. R. Stupp, M. E. Hegi, W. P. Mason, M. J. van den Bent, M. J. Taphoorn, R. C. Janzer, S. K. Ludwin, A. Allgeier, B. Fisher, K. Belanger, P. Hau, A. A. Brandes, J. Gijtenbeek, C. Marosi, C. J. Vecht, K. Mokhtari, P. Wesseling, S. Villa, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J. G. Cairncross, R. O. Mirimanoff, European Organisation for Research, Treatment of Cancer Brain Tumour and Radiation Oncology Groups, National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet. Oncol. 10, 459–466 (2009) doi: 10.1016/S1470–2045(09)70025–7

4. S.A. Kahn, D. Biasoli, C. Garcia, L.H. Geraldo, B. Pontes, M. Sobrinho, A.C. Frauches, L. Romao, R.C. Soletti, S. Assuncao Fdos, F. Tovar-Moll, J.M. de Souza, F.R. Lima, G. Anderluh, V. Moura-Neto, Equinatoxin II potentiates temozolomide- and etoposide-induced glioblastoma cell death. Current. Top. Med. Chem. 12, 2082–2093 (2012)

5. V. Moura-Neto, L. Campanati, D. Matias, C.M. Pereira, C. Freitas, J. M. Coelho-Aguiar, T.C.L.S. Spohr, A.L. Tavares-Gomes, D. Pinheiro-Aguiar, S.A. Kahn, J. Balça-Silva, B. Pontes, I. Porto-Carreiro, J. Faria, R.A.P. Martins, S. Lima-Costa, M. F. Dias-Costa, M.C. Lopes, F.R.S. Lima. Glioblastoma and the special role of adhesion molecules in their invasion, ed. by A. Sedo, R. Mentlein (Springer-Verlag Wien, 2014), p. 293. doi:10.1007/978–3–7091-1431-5

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multifaceted therapeutical role of low‐density lipoprotein receptor family in high‐grade glioma;Molecular Oncology;2024-09-14

2. Long noncoding RNA UNC5B-AS1 suppresses cell proliferation by sponging miR-24-3p in glioblastoma multiforme;BMC Medical Genomics;2024-04-09

3. Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties;European Journal of Medicinal Chemistry;2024-03

4. Antihistaminic Activity of Shikonin from Biotechnologically Grown Echium italicum L.;Biotechnology of Medicinal Plants with Antiallergy Properties;2024

5. Local administration of shikonin improved the overall survival in orthotopic murine glioblastoma models with temozolomide resistance;Biomedicine & Pharmacotherapy;2023-10